These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 20805028

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of a new aldose reductase inhibitor on various tissues in vitro.
    Terashima H, Hama K, Yamamoto R, Tsuboshima M, Kikkawa R, Hatanaka I, Shigeta Y.
    J Pharmacol Exp Ther; 1984 Apr; 229(1):226-30. PubMed ID: 6423811
    [Abstract] [Full Text] [Related]

  • 8. Docking and molecular dynamics study on the inhibitory activity of coumarins on aldose reductase.
    Wang Z, Ling B, Zhang R, Liu Y.
    J Phys Chem B; 2008 Aug 14; 112(32):10033-40. PubMed ID: 18637681
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Docking and molecular dynamics studies toward the binding of new natural phenolic marine inhibitors and aldose reductase.
    Wang Z, Ling B, Zhang R, Suo Y, Liu Y, Yu Z, Liu C.
    J Mol Graph Model; 2009 Sep 14; 28(2):162-9. PubMed ID: 19616461
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A, Tariq Shehzad M, Al Adhami T, Miraz Rahman K, Hussain D, Alharthy RD, Shafiq Z, Iqbal J.
    Bioorg Chem; 2021 Oct 14; 115():105164. PubMed ID: 34314916
    [Abstract] [Full Text] [Related]

  • 13. Factorizing selectivity determinants of inhibitor binding toward aldose and aldehyde reductases: structural and thermodynamic properties of the aldose reductase mutant Leu300Pro-fidarestat complex.
    Petrova T, Steuber H, Hazemann I, Cousido-Siah A, Mitschler A, Chung R, Oka M, Klebe G, El-Kabbani O, Joachimiak A, Podjarny A.
    J Med Chem; 2005 Sep 08; 48(18):5659-65. PubMed ID: 16134934
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Merging the binding sites of aldose and aldehyde reductase for detection of inhibitor selectivity-determining features.
    Steuber H, Heine A, Podjarny A, Klebe G.
    J Mol Biol; 2008 Jun 20; 379(5):991-1016. PubMed ID: 18495158
    [Abstract] [Full Text] [Related]

  • 17. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH, Sennitt CM, Ross H, Dingle A, Timms D, Mirrlees DJ, Tuffin DP.
    Biochem Pharmacol; 1990 Jan 15; 39(2):337-46. PubMed ID: 2105733
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Virtual screening of epalrestat mimicking selective ALR2 inhibitors from natural product database: auto pharmacophore, ADMET prediction and molecular dynamics approach.
    Choudhary S, Silakari O.
    J Biomol Struct Dyn; 2022 Aug 15; 40(13):6052-6070. PubMed ID: 33480327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.